WordNet

join for a common purpose or in a common action; "These forces combined with others"
harvester that heads and threshes and cleans grain while moving across the field
add together from different sources; "combine resources"
impose a blockade on (同)seal off
a war measure that isolates some area of importance to the enemy (同)encirclement
prevents access or progress
obstruct access to (同)block off
(medicine) the act of caring for someone (as by medication or remedial training etc.); "the quarterback is undergoing treatment for a knee injury"; "he tried every treatment the doctors suggested"; "heat therapy gave the best relief"
male sex hormone that is produced in the testes and responsible for typical male sexual characteristics (同)androgenic_hormone
blocking entrance to and exit from seaports and harbors; "the blockading ships prevented delivery of munitions"

PrepTutorEJDIC

…'を'『結合する』,合同する / …'を'兼ね備える;(…と)…'を'兼ね合わさせる《+『名』+『with』+『名』》 / …'を'化合させる;(…と)…'を'化合させる《+『名』+『with』+『名』》 / 『結合する』,連合する,合同する / (…と)化合する《+『with』+『名』》 / 連合,合同;(特に)企業合同,政治連合 / (また『combine harvester』)(刈り取りと脱穀が同時にできる)複式収穫機,コンバイン
(軍事力による港・海岸線などの)封鎖,閉鎖 / 封鎖を行う軍隊 / 障害物,妨害物 / (軍事力により)〈港など〉'を'封鎖する
(病気の)治療,療法 / =psychotherapy
アンドロゲン(男性ホルモン)

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 播種性転移した去勢感受性前立腺癌の治療法の概要 overview of the treatment of disseminated castration sensitive prostate cancer
2. 去勢感受性前立腺癌の初期全身療法 initial systemic therapy for castration sensitive prostate cancer
3. 中リスク、高リスク、超高リスクの限局性前立腺癌の初期マネージメント initial management of regionally localized intermediate high and very high risk prostate cancer
4. 限局性前立腺癌治療後の血清PSAの上昇：全身療法 rising serum psa after treatment for localized prostate cancer systemic therapy
5. 悪性唾液腺腫瘍：再発性および転移性疾患の治療 malignant salivary gland tumors treatment of recurrent and metastatic disease

西原千香子,鞍作克之,田中智章 [他]
泌尿器科紀要 57(4), 209-212, 2011-04
… After 10-month maximal androgen blockade(MAB) and arterial cemotherapy using reservoir system, radiation therapy was performed. …
NAID 40018771630

Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second-line anti-androgen

NARIMOTO Kazutaka,MIZOKAMI Atsushi,IZUMI Kouji,MIHARA Shinya,SAWADA Kiyoshi,SUGATA Toshiaki,SHIMAMURA Masayoshi,MIYAZAKI Kimiomi,NISHINO Akio,NAMIKI Mikio
International journal of urology 17(4), 337-345, 2010-04-01
… Objectives: To analyze the clinical effects of flutamide as a second-line anti-androgen for combined androgen blockade in patients with castration-resistant prostate cancer (CRPC) initially treated with bicalutamide as a first-line anti-androgen. … Methods: Our study population consisted of 16 patients with CRPC who were treated with flutamide (375 mg daily) as second-line hormonal therapy. …
NAID 10027257963